Author: Benjamin Aghaki-Allen - Page 3

1

Dec

How States Use Incentives to Push Generic Drug Prescribing

How States Use Incentives to Push Generic Drug Prescribing

States use preferred drug lists, pharmacist substitution rules, and copay differentials to encourage generic drug use-saving billions without sacrificing care. Here's how these policies work and why they matter.

VIEW MORE
28

Nov

Black Box Warnings on Antidepressants for Youth: What the Data Really Shows

Black Box Warnings on Antidepressants for Youth: What the Data Really Shows

The FDA's black box warning on antidepressants for youth was meant to reduce suicide risk - but data shows it led to fewer prescriptions and more suicide attempts. What the evidence really says about risks and real-world harm.

VIEW MORE
27

Nov

Pharmacist Responsibility for Reporting Generic Drug Problems

Pharmacist Responsibility for Reporting Generic Drug Problems

Pharmacists play a vital role in spotting and reporting generic drug problems like therapeutic inequivalence and adverse reactions. Learn why their reports matter, what to report, and how to do it-even when no law requires it.

VIEW MORE
26

Nov

Statins and Nonalcoholic Fatty Liver Disease: Safety, Benefits, and How to Monitor Them

Statins and Nonalcoholic Fatty Liver Disease: Safety, Benefits, and How to Monitor Them

Statins are safe and beneficial for people with nonalcoholic fatty liver disease (NAFLD). They reduce heart attack risk, lower liver enzymes, and don't cause liver damage. Learn the facts, guidelines, and monitoring steps.

VIEW MORE
25

Nov

Generic vs Brand-Name Drugs: Key Differences Explained

Generic vs Brand-Name Drugs: Key Differences Explained

Generic drugs save up to 85% on costs and work just as well as brand-name versions. Learn how the FDA ensures they're safe, why they look different, and when you might notice a difference.

VIEW MORE
24

Nov

Drug-Disease Interactions: When Health Conditions Affect Medications

Drug-Disease Interactions: When Health Conditions Affect Medications

Drug-disease interactions occur when medications for one condition worsen another. Learn how common conditions like kidney disease, heart failure, and diabetes can make standard drugs dangerous - and what you can do to stay safe.

VIEW MORE
23

Nov

OTC Cough Suppressants vs. Expectorants: How to Choose the Right One for Your Cough

OTC Cough Suppressants vs. Expectorants: How to Choose the Right One for Your Cough

Learn how to tell the difference between OTC cough suppressants and expectorants so you pick the right one for your cough. Stop wasting money and risking your health with the wrong medicine.

VIEW MORE
22

Nov

Lupus Arthritis: How Hydroxychloroquine Reduces Joint Inflammation and Flares

Lupus Arthritis: How Hydroxychloroquine Reduces Joint Inflammation and Flares

Hydroxychloroquine is the cornerstone treatment for lupus arthritis, reducing joint inflammation, preventing flares, and protecting organs. Learn how it works, why it's recommended for nearly all lupus patients, and what to expect when taking it.

VIEW MORE
21

Nov

Direct-to-Consumer Generic Pharmacies: How Much You Really Save vs Insurance

Direct-to-Consumer Generic Pharmacies: How Much You Really Save vs Insurance

DTC pharmacies like Amazon and Mark Cuban's Cost Plus Drug Company can save you hundreds on expensive generics - but not always. Learn when cash pay beats insurance and when it doesn't.

VIEW MORE
20

Nov

Medications to Avoid with COPD: Preventing Respiratory Compromise

Medications to Avoid with COPD: Preventing Respiratory Compromise

Certain medications can worsen COPD symptoms or cause life-threatening breathing problems. Learn which drugs to avoid-including opioids, benzodiazepines, non-selective beta-blockers, and anticholinergics-and what safer alternatives exist.

VIEW MORE
20

Nov

Hatch-Waxman Act: How U.S. Law Made Generic Drugs Affordable and Accessible

Hatch-Waxman Act: How U.S. Law Made Generic Drugs Affordable and Accessible

The Hatch-Waxman Act revolutionized U.S. drug access by creating a fast, affordable path for generic drugs. It balances innovation with competition, saving billions annually and making medications accessible to millions.

VIEW MORE
19

Nov

Stability Testing Requirements: Temperature and Time Conditions for Pharmaceutical Products

Stability Testing Requirements: Temperature and Time Conditions for Pharmaceutical Products

Stability testing ensures pharmaceuticals remain safe and effective over time. Learn the exact temperature and time conditions required by ICH Q1A(R2), global regulatory differences, real-world challenges, and what's changing in 2025.

VIEW MORE

Categories

Popular posts

Popular tags

Menu

© 2025. All rights reserved.